Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleSwitching "Real-World" Diabetes Patients to Degludec from Other Basal Insulins Provides Different Clinical Benefits According to Their Baseline Glycemic Control.AuthorsTentolouris, Nikolaos; Knudsen, Søren T.; Lapolla, Annunziata; Wolden, Michael Lyng; Haldrup, Steffen; Schultes, BerndPublicationAdvances in Therapy, 2019, Vol 36, Issue 5, p1201ISSN0741-238XPublication typejournal articleDOI10.1007/s12325-019-00916-7